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Relationship between Vitamin D, Parathyroid Hormone, and 
Bone Mineral Density in Elderly Koreans 
There is controversy regarding definition of vitamin D inadequacy. We analyzed threshold 
25-hydroxyvitamin D (25[OH]D) below which intact parathyroid hormone (iPTH) increases, 
and examined age- and sex-specific changes of 25(OH)D and iPTH, and association of 
25(OH)D and iPTH with bone mineral density (BMD) in elderly Koreans. Anthropometric 
parameters, serum 25(OH)D and iPTH, lumbar spine and femur BMD by dual-energy 
radiography absorptiometry (DXA) were measured in 441 men and 598 postmenopausal 
women. iPTH increased below serum 25(OH) of 36.7 ng/mL in men, but failed to reach 
plateau in women. Femur neck BMD above and below threshold differed when threshold 
25(OH)D concentrations were set at 15-27.5 ng/mL in men, and 12.5-20 ng/mL in 
postmenopausal women. Vitamin D-inadequate individuals older than 75 yr had higher 
iPTH than those aged  ≤ 65 yr. In winter, age-associated iPTH increase in women was 
steeper than in summer. In conclusion, vitamin D inadequacy threshold cannot be 
estimated based on iPTH alone, and but other factors concerning bone health should also 
be considered. Older people seemingly need higher 25(OH)D levels to offset age-associated 
hyperparathyroidism. Elderly vitamin D-inadequate women in the winter are most 
vulnerable to age-associated hyperparathyroidism.
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INTRODUCTION
Vitamin D plays an important role in skeletal development and 
maintenance. Chronic vitamin D inadequacy in adults can re-
sult in compensatory hyperparathyroidism, leading to increased 
bone turnover, enhanced bone loss, and increased risk of fragil-
ity fracture. Therefore maintaining appropriate levels of serum 
25(OH)D and iPTH is important for bone health (1-3). In addi-
tion to its well known skeletal effect, vitamin D plays an impor-
tant role in maintaining muscle balance and function, as well 
as inhibiting the development of autoimmune diseases, cancer, 
heart disease, and cognitive dysfunction (4-7). 
  Factors that have been reported to be associated with vitamin 
D inadequacy include skin pigmentation, sunlight exposure, 
dietary intake, medications, body fat content, and age (4, 8-10). 
Increased age has especially been associated with lower 25(OH)
D levels owing to changes in lifestyle factors such as clothing and 
decreased outdoor activities, and owing to reduced cutaneous 
vitamin D synthesis capacity and dietary intake of vitamin D. 
Whether age per se is associated with higher iPTH levels is con-
troversial, but recent investigations have shown that older peo-
ple require higher levels of serum 25(OH)D compared with 
younger people to offset compensatory hyperparathyroidism 
(11, 12). It has also been reported that serum 25(OH)D levels 
decline with age earlier in women than in men and less efficient-
ly prevent compensatory hyperparathyroidism in older adults 
(11). However, the association between age and 25(OH)D and 
iPTH has mostly been studied on populations that include rela-Kim G, et al.  •  Vitamin D and Bone Health
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tively young individuals and there are not many studies limited 
to old people. 
  Though definitions of vitamin D inadequacy vary and several 
cutoff levels for vitamin D inadequacy have been suggested, it 
is now generally accepted that serum 25(OH)D concentration 
of 30 ng/mL* (*Conversion of ng/mL units to nM/L can be ac-
complished by multiplying the reported serum 25(OH)D value 
in ng/mL by 2.5.) is the threshold for vitamin D inadequacy (13, 
14). This threshold was derived from the 25(OH)D levels at which 
iPTH levels reach a plateau in many reports. However, iPTH 
alone is not enough to define the vitamin D inadequacy thresh-
old (15). Studies on the relation between 25(OH)D levels and 
BMD are necessary to evaluate the actual effects of vitamin D 
levels on bone health. Moreover, since old people are more prone 
to secondary hyperparathyroidism due to factors such as de-
creased intestinal calcium absorption, the vitamin D inadequa-
cy threshold in elderly people should be separately addressed. 
  In this study, we analyzed the relation between serum 25(OH)
D levels, iPTH levels and BMD values in elderly individuals liv-
ing in a Korean rural community. Age- and sex-related changes 
of 25(OH)D and iPTH will also be addressed in our study. To 
our knowledge this would be one of the first large-scale com-
munity based study on vitamin D and iPTH levels on elderly 
Koreans.
 
MATERIALS AND METHODS
Study subjects
Study subjects were participants of the Catholic Metabolic dis-
ease Cohort (CMC) Study (16). The Catholic Metabolic disease 
Cohort Study is a longitudinal cohort study which began in 2003, 
based in the Chungju suburb community. Chungju is a city  
located in the center of the Korean Peninsula, in North Chun-
gcheong province, at latitude 36.6 north. Through the stratified 
cluster sampling method, 1/4 of inhabitants aged 40 yr and over 
was recruited annually from each suburban area in Chungju. 
We performed a cross-sectional evaluation of the results of 1,069 
ambulatory individuals aged 50 yr and over who participated 
the Catholic Metabolic disease Cohort Study from May 2007 until 
February 2008. Individuals were excluded who had creatinine 
clearance values less than 30 mL/min according to the Cock-
croft-Gault equation* (*Cockcroft-Gault equation: creatinine 
clearance = [140-age] × [Wt in kg] × [0.85 if female]/[72 × Cr]), 
who had underlying chronic kidney disease or thyrotoxicosis or 
current cancer at the time of the investigation, who had used 
steroids for more than 3 consecutive months, who had been 
treated with bisphosphonates or selective estrogen receptor 
modulators or estrogen hormone or calcitonin, or who did not 
have adequate blood samples for measurement of 25(OH)D. 
Women who were in the premenopausal or perimenopausal 
state, or who had a history of bilateral oophorectomy were ex-
cluded. Menopause was defined as the absence of menstrua-
tion for at least 12 months. 
Clinical evaluation
Information regarding past medical history, past fracture histo-
ry, family history of fracture, current and prior medication use, 
exercise (≥ 3 times per week vs  < 3 times per week), smoking 
(yes or no), alcohol drinking (≥ 4 times per week vs  < 4 times 
per week) and educational attainment was collected. Education 
attainment was categorized as less than elementary education, 
elementary school graduate, middle school graduate, high school 
graduate, and college graduate. Dietary calcium intake was as-
sessed with a previously validated food-frequency question-
naire (FFQ) which used the 3-day diet record method (17). 
BMD measurement 
BMD of the lumbar spine (L1-4) and femur was measured us-
ing DXA (Hologic DQR 4500, Waltham, USA) by a single techni-
cian. Body mass index (BMI) was calculated by dividing body 
weight (kg) by the square of body height (m
2). The coefficients 
of variation (CVs) of the BMD measurements were 1.36% for 
the lumbar spine and 1.5% for the total femur. 
Biochemical measurements
A 12-h-fasting blood specimen was drawn from each individu-
al. Serum was stored at -70°C within 30 min of blood draw. Se-
rum 25(OH)D concentration was measured with the Liaison
® 
TOTAL chemiluminescent immunoassay (CLIA) (DiaSorin, Still-
water, Minnesota, USA) which has an inter-assay CV value of 
6.3% and an intra-assay CV value of 2.9%. The limit of detection 
was 4.0 ng/mL and the reference range was 4.8-52.8 ng/mL. Since 
there are large interlaboratory differences in assays for serum 
25(OH)D (18, 19), serum 25(OH)D levels were measured with 
both the Diasorin Liaison
® TOTAL CLIA and Diasorin radioim-
munoassay (RIA) (DiaSorin, Stillwater, Minnesota, USA, intra- 
and inter-assay CV: 4.0% and 5.3% respectively) for interassay 
comparison in 100 individuals who were randomly selected in 
an age- and sex-matched method from the cohort. The serum 
iPTH concentration was measured with the Liaison
® N-tact
TM 
PTH Assay (DiaSorin, Stillwater, Minnesota, USA), which has 
an intra- and interassay CV of 3.7% and 3.5%, respectively. All 
biochemical measurements were performed in a central labo-
ratory (Neodin Medical Laboratories, Seoul, Korea) for accura-
cy and consistency. 
Statistical analyses
Pearson’s product moment correlation coefficient was used to 
assess correlations between continuous variables. Partial corre-
lation analysis was performed to adjust for confounding factors. 
Student’s t-test was used to test a difference in two mean values. 
One-way analysis of variance (ANOVA) with Tukey’s or Dun-Kim G, et al.  •  Vitamin D and Bone Health
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nett’s multiple comparison was used to test differences among 
multiple mean values. An analysis of covariance (ANCOVA) was 
performed to test for differences in mean values while adjusting 
for cofactors. A probability value of P < 0.05 was taken as statis-
tically significant. All statistical analyses were performed using 
SPSS Version 15.0 and SAS Version 9.1 for Windows software 
(SAS Institute Inc., Cary, NC, USA).
Ethics statement
This study was approved by the institutional review board at 
Seoul St. Mary’s hospital (KCMC070T076) and informed con-
sent was obtained from all participants.
 
RESULTS
Baseline characteristics
The sex-specific baseline characteristics of the participants are 
shown in Table 1. The study population comprised 441 (42.4%) 
men and 598 (57.6%) postmenopausal women. Seventy-two 
point six percent of men and 80.1% of women were in their six-
ties and seventies resulting in no significant difference between 
the mean ages of the two genders. Eighty point two percent of 
men and 61.7% of women were farmers, respectively. Sixty- 
seven point one percent of men and 92.2% of women received 
less than middle school education. Twenty-nine point nine per-
cent of men took alcohol 4 times or over per week whereas only 
2% of women drank such amounts. Thirty-two point seven per-
cent of men and 4.6% of postmenopausal women were smok-
ers, respectively. The mean serum 25(OH)D concentration was 
21.6 ± 7.4 ng/mL in men and 16.6 ± 5.9 ng/mL in postmeno-
pausal women. 
Association between 25(OH)D and iPTH
25(OH)D had a negative correlation with iPTH in men (r = -0.249, 
P < 0.001) and women (r = -0.228, P < 0.001), respectively. The 
values for vitamin D and iPTH were plotted on a scatter plot for 
each sex, and the exponential decay model was used to assume 
the 25(OH)D level at which iPTH concentrations theoretically 
attain the plateau value. The 25(OH)D and iPTH concentrations 
for each sex were fit to a three-parameter exponential decay 
function using the approach used by Chapuy et al. (19). The re-
sulting exponential decay formulas were as follows:
  iPTH (pg/mL)
           = 39.2 + 47.9 exp (-0.08 × 25[OH]D [ng/mL]) (men) 
  iPTH (pg/mL)
           = 22.6 + 46.0 exp (-0.03 × 25[OH]D [ng/mL]) (women) 
  With this approach, the iPTH concentration reached a theo-
retical plateau at 41.6 pg/mL and the corresponding 25(OH)D 
level was 36.7 ng/mL in men. In women, the exponential decay 
function failed to identify a plateau for serum iPTH (Fig. 1). 
Twelve of the 441 men (2.7%) had 25(OH)D levels equal to or 
above 36.7 ng/mL. 
Association of 25(OH)D and iPTH with BMD
Partial correlation analysis was performed to analyze the rela-
tion between 25(OH)D and iPTH with BMD with adjustment 
Table 1. Demographics, serum biochemical profiles, physical performance measures, and bone mineral density of study subjects  
Parameters Men (n = 441) Postmenopausal women (n = 598) P value
25(OH)D (ng/mL)*   21.6 ± 7.4   16.6 ± 5.9 < 0.001
Parathyroid hormone (pg/mL)
†     49.2 ± 21.9     51.7 ± 23.4 0.065
Age (yr)   66.2 ± 9.1   67.5 ± 7.5 0.025
Height (cm) 164.3 ± 5.9 150.3 ± 5.6 < 0.001
Weight (kg)   61.6 ± 9.4   54.2 ± 8.5 < 0.001
BMI (kg/m
2)   22.8 ± 3.0   24.0 ± 3.2 < 0.001
BMD of lumbar spine (g/cm
2)     0.893 ± 0.166     0.726 ± 0.137 < 0.001
BMD of total femur (g/cm
2)     0.889 ± 0.127     0.719 ± 0.120 < 0.001
BMD of femoral neck (g/cm
2)     0.745 ± 0.126     0.591 ± 0.114 < 0.001
Exercise ≥ 3 times per week, n (%)     30 (6.0)     46 (7.2) 0.406
Alcohol intake ≥ 4 times per week, n (%)     149 (29.9)     13 (2.0) < 0.001
Current smoker, n (%)     163 (32.7)     29 (4.6) < 0.001
Calorie intake (kcal/day)  1,499.5 ± 415.0  1,374.6 ± 325.3 < 0.001
Calcium intake (mg/day)     298.3 ± 182.8     289.7 ± 188.7 0.471
Personal history of fragility fracture, n (%)     41 (8.2)     102 (16.1) < 0.001
Family history of fracture, n (%)     39 (7.8)     45 (7.1) 0.404
Faller, n (%)       54 (10.8)     124 (19.5) < 0.001
Calcium (mg/dL)     9.5 ± 0.6     9.5 ± 0.6 0.732
Phosphorus (mg/dL)     3.5 ± 0.5     3.9 ± 0.5 < 0.001
Albumin (mg/dL)     4.8 ± 0.4     4.7 ± 0.3  0.009
Creatinine clearance (mL/min)     69.4 ± 17.9     64.6 ± 17.5 < 0.001
Continuous variables were compared using unpaired T-test; categorical variables were compared using Chi-square test. Data are expressed as mean ± SD. *To convert results 
to SI units: ng/mL × 2.5 = nM/L; 
†To convert results to SI units: pg/mL × 0.106 = pM/L. Kim G, et al.  •  Vitamin D and Bone Health
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for age, height, weight, and creatinine clearance. Lumbar spine 
BMD had no significant correlation with either 25(OH)D or 
iPTH in both men and women after adjustment for age, height, 
weight, and creatinine clearance. Femur neck BMD was posi-
tively correlated with 25(OH)D in both men (r = 0.161, P = 0.001) 
and women (r = 0.143, P < 0.001) after adjustment. Femur neck 
BMD also negatively correlated with iPTH both in men (r = -0.104, 
P = 0.027) and women (r = -0.030, P = 0.468) after adjustment, 
though this did not reach statistical significance in women  
(Table 2). 
  For every 2.5 ng/mL increment in 25(OH)D concentrations, 
iPTH and femur neck BMD values were compared around the 
specific 25(OH)D values from 10 ng/mL to 30 ng/mL with ad-
justment for age, height, weight, and creatinine clearance. There 
were significant differences between femur neck BMD values 
when the cut off 25(OH)D concentrations were 15-27.5 ng/mL in 
men, and 12.5-20 ng/mL in postmenopausal women. The coef-
ficient of determination was greatest in both sex when 25(OH)
D concentration was 15 ng/mL (R
2 = 0.279 in men, R
2 = 0.387 in 
postmenopausal women) (Tables 3, 4).
  iPTH and lumbar spine and femur neck BMDs were com-
pared among men who had 25(OH)D levels  ≥ 36.7 ng/mL and 
< 36.7 ng/mL. There were no statistically significant differences 
in iPTH levels, lumbar spine BMD, and femur neck BMD values 
(data not shown). 
Fig. 1. Relationship between serum (iPTH) and 25-hydroxyvitamin D (25(OH)D) values in men (A) and postmenopausal women (B). For a 25(OH)D concentration higher than 
36.7 ng/mL, there is a plateau level at 41.6 pg/mL for iPTH in men. In women, the exponential decay function failed to identify a plateau for serum iPTH.
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Table 2. Correlation analysis between iPTH, 25(OH)D, and BMD values with and with-
out adjustment (Adjustment was performed for age, height, weight, and creatinine 
clearance)
Parameters
25(OH)D iPTH
r P value r P value
Before adjustment
   Men (n = 441)
      25(OH)D
      iPTH
      Lumbar spine BMD
      Femur neck BMD
   Postmenopausal women (n = 598)
      25(OH)D
      iPTH
      Lumbar spine BMD
      Femur neck BMD
  
 
 
-0.249
-0.020
0.169
 
-0.228
0.025
0.086
 
 
 
< 0.001
0.665
< 0.001
 
 
< 0.001
0.539
0.035
 
 
-0.249
 
-0.003
-0.107
 
-0.228
 
-0.085
-0.091
 
 
< 0.001
 
0.941
0.021
 
< 0.001
 
0.037
0.026
After adjustment
   Men (n = 441)
      25(OH)D
      iPTH
      Lumbar spine BMD
      Femur neck BMD
   Postmenopausal women (n = 598)
      25(OH)D
      iPTH
      Lumbar spine BMD
      Femur neck BMD
 
  
 
-0.244
-0.006
0.161
 
 
-0.229
0.063
0.143
 
 
 
< 0.001
0.897
0.001
 
 
< 0.001
0.126
< 0.001
 
 
-0.244
 
0.007
-0.104
 
-0.229
 
-0.068
-0.030
 
 
< 0.001
 
0.889
0.027
 
< 0.001
 
0.098
0.468
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Fig. 2. Serum parathyroid hormone (PTH) levels according to 25(OH)D levels in differ-
ent age groups. Mean iTPH in individuals older than 75 yr were consistently higher 
than that of those aged 65 yr or younger, except in the lowest (25(OH)D < 10 ng/mL) 
vitamin D group (ANOVA, Dunnett’s multiple comparison test).Kim G, et al.  •  Vitamin D and Bone Health
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Association between CLIA and RIA
Serum 25(OH)D concentrations were measured with both the 
Diasorin Liaison
® TOTAL CLIA and Diasorin RIA method in 100 
subjects randomly selected in an age- and sex-matched meth-
od to represent the whole cohort. There was a good correlation 
between 25(OH)D levels measured with the CLIA and the RIA 
method (r = 0.920, P < 0.001). Serum 25(OH)D levels measured 
with the CLIA method were lower by an average of 5.6 ng/mL 
compared to levels measured with the RIA method according 
to the Bland-Altman method. 
Associations of Serum 25(OH)D and iPTH levels in 
relation to age and sex 
To compare iPTH levels between old and young individuals 
Table 3. Mean femur neck BMD around serum 25(OH)D levels of  2.5-ng/mL increments in men
25(OH)D values Mean femur neck BMD P value R
2
< 10 mg/mL (n = 19)
≥ 10 mg/mL (n = 422)
0.703 (0.730*)
0.738 (0.737*)
0.212 (0.945*) 0.252
< 12.5 mg/mL (n = 55)
≥ 12.5 mg/mL (n = 386)
0.698 (0.713*)
0.742 (0.740*)
0.010 (0.075*) 0.257
< 15 mg/mL (n = 94)
≥ 15 mg/mL (n = 347)
0.688 (0.698*)
0.750 (0.747*)
< 0.001 (< 0.001*) 0.279
< 17.5 mg/mL (n = 135)
≥ 17.5 mg/mL (n = 306)
0.712 (0.717*)
0.748 (0.746*)
0.004 (0.008*) 0.264
< 20 mg/mL (n = 180)
≥ 20 mg/mL (n = 261)
0.720 (0.723*)
0.749 (0.747*)
0.011 (0.018*) 0.261
< 22.5 mg/mL (n = 248)
≥ 22.5 mg/mL (n = 193)
0.727 (0.729*)
0.749 (0.747*)
0.060 (0.049*) 0.257
< 25 mg/mL (n = 306)
≥ 25 mg/mL (n = 135)
0.730 (0.730*)
0.753 (0.753*)
0.055 (0.032*) 0.259
< 27.5 mg/mL (n = 344)
≥ 27.5 mg/mL (n = 97)
0.731 (0.730*)
0.760 (0.763*)
0.035 (0.006*) 0.264
< 30 mg/mL (n = 390)
≥ 30 mg/mL (n = 51)
0.734 (0.734*)
0.760 (0.759*)
0.137 (0.115*) 0.256
*Adjusted for age, weight, height, and creatinine clearance. 
Table 4. Mean femur neck BMD around serum 25(OH)D levels of 2.5-ng/mL increments in postmenopausal women
25(OH)D values Mean femur neck BMD P value R
2
< 10 mg/mL (n = 75)
≥ 10 mg/mL (n = 523)
0.579 (0.573*)
0.590 (0.592*)
0.407 (0.104*) 0.376
< 12.5 mg/mL (n = 171)
≥ 12.5 mg/mL (n = 427)
0.575 (0.570*)
0.595 (0.597*)
0.055 (0.001*) 0.384
< 15 mg/mL (n = 262)
≥ 15 mg/mL (n = 336)
0.579 (0.574*)
0.597 (0.601*)
0.055 (< 0.001*) 0.387
< 17.5 mg/mL (n = 358)
≥ 17.5 mg/mL (n = 240)
0.585 (0.580*)
0.596 (0.603*)
0.237 (0.002*) 0.377
< 20 mg/mL (n = 425)
≥ 20 mg/mL (n = 173)
0.586 (0.584*)
0.598 (0.602*)
0.278 (0.024*) 0.373
< 22.5 mg/mL (n = 488)
≥ 22.5 mg/mL (n = 110)
0.588 (0.587*)
0.597 (0.598*)
0.449 (0.252*) 0.375
< 25 mg/mL (n = 532)
≥ 25 mg/mL (n = 66)
0.587 (0.588*)
0.608 (0.603*)
0.156 (0.198*) 0.375
< 27.5 mg/mL (n = 563)
≥ 27.5 mg/mL (n = 35)
0.588 (0.588*)
0.617 (0.608*)
0.232 (0.216*) 0.375
< 30 mg/mL (n = 589)
≥ 30 mg/mL (n = 9)
0.589 (0.589*)
0.597 (0.580*)
0.843 (0.765*) 0.374
*Adjusted for age, weight, height, and creatinine clearance.
with similar 25(OH)D levels, patients were grouped according 
to 25(OH)D levels by the increment of 5 ng/mL and were fur-
ther grouped into 3 age categories in each 25(OH)D group. Mean 
iPTH levels were compared across the age groups in each 25(OH)
D group (ANOVA, Dunnett’s multiple comparison test). Though 
the results did not reach statistical significance, mean iTPH in 
individuals older than 75 yr were consistently higher than that 
of those aged 65 yr or younger when 25(OH)D levels were with-
in the inadequacy range (Fig. 2). 
Age- and sex-specific changes in 25(OH)D and iPTH levels 
by seasons
Subjects were divided into those who had blood tests in the 
winter season (September-February) and the summer season Kim G, et al.  •  Vitamin D and Bone Health
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(May-August), respectively. Serum 25(OH)D levels were signifi-
cantly lower and serum iPTH levels significantly higher in the 
winter season compared with the summer season in both men 
(25[OH]D, 19.97 ± 7.19 vs 24.05 ± 7.04 ng/mL, P < 0.001; iPTH 
52.01 ± 23.74 vs 43.85 ± 14.53 pg/mL, P < 0.001) and women 
(25[OH]D, 15.58 ± 5.36 vs 18.06 ± 6.44 ng/mL, P < 0.001; iPTH, 
52.01 ± 23.74 vs 43.85 ± 14.53 pg/mL, P < 0.001), respectively. 
Men and women were further subcategorized by age (decades) 
in each season and mean 25(OH)D and iPTH levels were com-
pared among decades. 25(OH)D levels were lower in women 
than in men in most age groups both in the winter and summer 
seasons. There were no differences in 25(OH)D levels among 
different age groups in both men and women in the winter sea-
son. However, in the summer season, there was a significant 
progressive decrease in 25(OH)D levels with age in men but no 
significant difference in women. iPTH levels were significantly 
higher in women aged  ≥ 80 yr (P < 0.001; P < 0.001 after adjust-
ment for creatinine and BMI) and  ≥ 70 yr (P = 0.018; P = 0.047 
after adjustment for creatinine and BMI) in the winter and sum-
mer seasons, respectively (ANOVA, Dunnett’s multiple com-
parison test; ANCOVA, Bonferroni’s multiple comparison). On 
the contrary, there were no differences in iPTH levels among 
across decades in men both in the winter and the summer sea-
sons (Fig. 3). 
DISCUSSION
Recent influential reviews have stated that a serum 25(OH)D 
level of 30 ng/mL should be used as the threshold for vitamin D 
inadequacy. In the study analyzed in those reviews, serum iPTH 
showed a plateau at serum 25(OH)D of approximately 30 ng/mL. 
However, recent studies show that the 25(OH)D level at which 
iPTH levels attain a plateau cannot be used by itself to estimate 
the vitamin D inadequacy threshold (15). There are also studies 
that showed no iPTH plateau in the 25(OH)D-iPTH relation, 
which makes the choice of an optimal 25(OH)D concentration 
Fig. 3. Mean serum 25(OH)D and iPTH levels according to season and age in men and women. iPTH levels increased significantly in women aged ≥ 80 yr (P < 0.001) and 
≥ 70 yr (P = 0.018) in the winter and summer seasons, respectively. iPTH levels increased significantly in women aged ≥ 80 yr (P < 0.001; P < 0.001 after adjustment for 
creatinine clearance and BMI) and ≥ 70 yr (P = 0.018; P = 0.043 after adjustment for creatinine clearance and BMI) in the winter and summer seasons, respectively. Black 
boxes indicate men and blank circles indicate women; Dashed lines indicate mean values adjusted for BMI and creatinine clearance; Numbers in squared brackets indicate 
numbers of men and numbers in round brackets indicates numbers of postmenopausal women, respectively (ANOVA, Dunnett’s multiple comparison test, ANCOVA, Bonferroni’s 
multiple comparison).
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based only on iPTH arbitrary (14, 15). Moreover, since results 
from recent studies suggest relatively higher iPTH levels in old 
people, it would be necessary to separately address the 25(OH)-
iPTH relation in the elderly (15).
  Using the exponential decay model to describe the 25(OH)
D-iPTH relationship in our study, iPTH levels reached a plateau 
when 25(OH)D concentration was 36.7 ng/mL in men and iPTH 
levels failed to reach a plateau in women. The 25(OH)D concen-
tration of 36.7 ng/mL in men far exceeds the consensus thresh-
old for vitamin D inadequacy. When femur neck BMD values 
around 36.7 ng/mL were compared in men, there were no dif-
ferences. This may partly be attributable to the small number of 
men with 25(OH)D levels  ≥ 36.7 ng/mL, but further results from 
our study suggest otherwise.
  When femur neck BMD values were compared around spe-
cific 25(OH)D values from 10 ng/mL to 30 ng/mL, femur neck 
BMD values differed when the cut off 25(OH)D concentrations 
were 15-27.5 ng/mL in men. Also, in postmenopausal women, 
femur neck BMD values were different when they were com-
pared around 25(OH)D concentrations of 12.5-20 ng/mL. The 
coefficient of determination was greatest in both sex when 
25(OH)D concentration was 15 ng/mL. 
  Our results show that the threshold vitamin D value cannot 
be determined in the context of iPTH levels alone, and that the 
adequate 25(OH)D levels should also be evaluated in the con-
text of other factors concerning bone health, such as BMD. In 
order to further determine the threshold vitamin D level, mea-
surements on bone turnover markers, and intestinal calcium 
and phosphorus absorption should also be performed. 
  Though lumbar spine BMD did not correlate with 25(OH)D 
and iPTH levels, femur neck BMD was positively correlated with 
25(OH)D and negatively correlated with iPTH, in both men and 
women. (However, femur neck BMD values did not have a statis-
tically significant correlation with iPTH levels in women.) Simi-
lar associations have been reported in other studies (20, 21). 
Degenerative changes in the lumbar spine, aortic and extraskel-
etal calcification associated with aging may falsely elevate lum-
bar spine BMD and hence result in a non-specific association 
between 25(OH)D and lumbar spine BMD (22). Also, it is known 
that iPTH-mediated bone resorption preferentially involves cor-
tical bone than trabecular bone. Since the femur contains more 
cortical bone, it is likely that elevated iPTH levels secondary to 
decreased serum 25(OH)D concentrations may have affected 
the femur more than the spine.
  When study subjects were categorized into 3 age groups and 
iPTH concentrations were compared among those who had 
similar 25(OH)D levels, iPTH concentration of the oldest age 
group was consistently higher than that of younger age groups. 
This probably implies that older people need higher 25(OH)D 
levels to offset age-associated hyperparathyroidism. These re-
sults are in line with data from women in our cohort. 
  Older women had higher iPTH levels compared with younger 
women throughout the year though vitamin D levels were not 
significantly different among the age groups. The rise in iPTH 
level was most prominent in women aged  ≥ 80 yr in the winter 
season, which may have been attributable to the especially lower 
levels of serum 25(OH)D in this season caused by less sunshine 
exposure.
  Similar results have been obtained in other studies (13, 14), 
but these studies included young individuals, and age-related 
changes of 25(OH)D and iPTH levels limited to old people have 
not been evaluated so far. This study excluded individuals aged 
less than 50 yr, thus giving a perspective into 25(OH)D and iPTH 
levels in old people. Our results also suggest that older women 
may be less efficient at preventing secondary hyperparathyroid-
ism caused by low 25(OH)D levels, compared with men and 
younger women. 
  Some studies have shown that intestinal calcium absorption 
decreases with aging, probably due to intestinal resistance to 
1,25(OH)2D, which leads to compensatory increases in iPTH 
secretion and 1,25(OH)D production, to maintain calcium ab-
sorption and serum ionic calcium (23, 24). Such factors may have 
contributed to the relatively high iPTH levels in the older individ-
uals in our study. Also, the higher iPTH levels in older women in 
the winter season may be attributable to the fact that these wom-
en had the lowest 25(OH)D levels among all the study subjects. 
The low 25(OH)D levels, in turn, would have probably resulted 
from the limited outdoor activities of old women compared to 
the rest of the individuals in the winter season. Since there were 
relatively small numbers of individuals aged  ≥ 80 yr, more study 
subjects would be required to further evaluate this phenomenon. 
  There are some limitations in our study that should be ac-
knowledged. The cross-sectional design of our study limits any 
causal inferences. Also, our study was performed on very old 
people dwelling in a rural area and whose educational and eco-
nomical statuses were very poor. Therefore the results of our 
study cannot be extended to the general population. However, 
this study was performed on a relatively large population, and 
the exclusion of young people from the study allowed the au-
thors to focus on age-related changes of serum 25(OH)D and 
iPTH in elderly people, and to assess the correlation between 
25(OH)D and iPTH with BMD in such a population. 
  In conclusion, this study shows that the desirable level of se-
rum 25(OH)D cannot be estimated based on iPTH alone, and 
that other factors concerning bone health, such as BMD, should 
also be considered to evaluate the optimal level of vitamin D. 
This study also shows that older people have higher iPTH levels 
compared with younger people with similar 25(OH)D levels. 
Therefore older people would require higher levels of 25(OH)D 
to offset age-related compensatory hyperparathyroidism. This 
phenomenon was most prominent in the oldest women in our 
cohort, especially in the winter season, which implies that elder-Kim G, et al.  •  Vitamin D and Bone Health
http://jkms.org   643 http://dx.doi.org/10.3346/jkms.2012.27.6.636
ly vitamin D-inadequate women in the winter are most vulner-
able to age-associated hyperparathyroidism.
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